Status:
COMPLETED
Brain Markers of Treatment Response in Post-Traumatic Stress Disorder (PTSD)
Lead Sponsor:
US Department of Veterans Affairs
Conditions:
Post-traumatic Stress Disorder
Eligibility:
All Genders
21-55 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to examine if treatment of post-traumatic stress disorder in combat veterans with paroxetine changes brain responses as measured by functional magnetic resonance imaging a...
Eligibility Criteria
Inclusion
- Veterans with clinical diagnosis of post-traumatic stress disorder from combat related to deployment to Afghanistan/Iraq (Operation Enduring Freedom/Operation Iraqi Freedom)
Exclusion
- Intolerance or sensitivity to paroxetine
- Major medical or neurologic illness
- Current psychotropic medication or active psychotherapy treatment
- Other major psychiatric illness
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT00700999
Start Date
October 1 2008
End Date
March 1 2012
Last Update
June 3 2014
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Jesse Brown VA Medical Center Community-Based Outpatient Clinic Lake Side Divison, Chicago, IL
Chicago, Illinois, United States, 60611
2
Jesse Brown VA Medical Center, Chicago, IL
Chicago, Illinois, United States, 60612
3
VA Ann Arbor Healthcare System, Ann Arbor, MI
Ann Arbor, Michigan, United States, 48113